Company / Assets per Share
PACIFIC BIOSCIENCES OF CALIFORNIA, INC. Assets per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Assets per Share
$2.61
FY2025
5-year range
$2.61 / $9.83
FY2021-FY2025
Trend
-40.2%
vs FY2024
Sector context
#152 of 158
Health Care
What the data says
Among 158 Health Care companies, PACIFIC BIOSCIENCES OF CALIFORNIA, INC. is in the bottom 4% for assets per share. Assets per Share has declined for 4 consecutive years, from $9.83 in FY2021 to $2.61 in FY2025.
Based on SEC 10-K filings.
2.61 in FY2025 with a 5-year CAGR of +2.0%.
Declined from $6.88 to $2.61 over the past 2 years.
Health Care sector context is included.
Assets per Share over time
Growth rates
- 3-Year CAGR
- -30.7%
- 5-Year CAGR
- +2.0%
- 10-Year CAGR
- -
Sector benchmark
Bottom 4% in Health CareTop 96% of 158This company $2.61 Sector average $116.83
▼
-97.8% below sector average
Key checks
Key Insights
- PACIFIC BIOSCIENCES OF CALIFORNIA, INC.'s assets per share has declined for 4 consecutive years.
- In FY2025, assets per share decreased 40.2% year-over-year.
- Ranks #152 out of 158 companies in the Health Care sector.
- Peak assets per share was recorded in FY2021.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -1.92 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.61 | -40.2% |
| FY2024 | $4.37 | -36.5% |
| FY2023 | $6.88 | -12.5% |
| FY2022 | $7.87 | -20.0% |
| FY2021 | $9.83 | +315.5% |
| FY2020 | $2.37 | +143.9% |
| FY2019 | $0.97 | -33.7% |
| FY2018 | $1.46 | -5.8% |
| FY2017 | $1.55 | -9.8% |
| FY2016 | $1.72 | -2.8% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026